Recombinant PCSK9 (Alirocumab Biosimilar) antibody
This Mammalian Cells Monoclonal antibody specifically detects PCSK9 (Alirocumab Biosimilar) in ELISA. It exhibits reactivity toward Human.
Catalog No. ABIN7487990
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant PCSK9 (Alirocumab Biosimilar) antibody (ABIN7487990)
Target
PCSK9 (Alirocumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This PCSK9 (Alirocumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Alirocumab Biosimilar - Anti-PCSK9 mAb
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- PCSK9 (Alirocumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
REGN727,SAR-236553
Alirocumab is a human IgG2 monoclonal antibody that binds to and prevents the binding of the proprotein convertase subtilisin/kexin type 9 (PCSK9). PCSK9 is a protein that binds to LDL receptors for degradation, thus reducing the liver’s activity of removal of LDL-cholesterol (LDL-C) from the blood. It is used in the treatment of hyperlipidemia. -
CAS-No
- 1245916-14-6
Target
-
You are here:
